Art

J-GLOBAL ID：201702290443883308   Reference number：17A0337254

乳がん治療におけるQuality of Life-評価と解釈

Author (1)： TAIRA NARUTO (岡山大 病院 乳腺・内分泌外科)
Material： Clinician  (クリニシアン)
Volume： 64  Issue： 655  Page： 181-186  Publication year： Mar. 01, 2017 
JST Material Number： X0015A  ISSN： 0387-1541  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： QOL scale

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0337254&from=J-GLOBAL&jstjournalNo=X0015A") }}

JST classification (1)： Clinical oncology in general  (GE03010Y)

Reference (4)：

• McQuellon RP, et al : Patient preferences for treatment of metastatic breast cancer : a study of women with early-stage breast cancer. J Clin Oncol, 13, 858-868 (1995)
• Di Maio M, et al: Symptomatic toxicities experienced during anticancer treatment:agreement between patient and physician reporting in three randomized trials. J Clin Oncol, 10, 910-915 (2015)
• U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH):Guidance for Industry-Patient-Reported Outcome Measures : Use in Medical Product Development to Support Labeling Claims (2009) http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
• Eton DT, et al: A combination of distribution-and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol, 57, 898-910 (2004)

Terms in the title (3)： 乳がん ,  治療 ,  評価